Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 14,002,300 | 8,419,800 | 2,759,300 | 10,590,000 | 6,180,200 |
| Depreciation Amortization | 1,411,300 | 941,300 | 462,800 | 1,766,600 | 1,281,800 |
| Income taxes - deferred | -958,900 | -1,460,300 | -391,600 | -2,683,100 | -1,716,400 |
| Accounts receivable | N/A | N/A | N/A | -2,155,200 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 2,608,800 | N/A |
| Other Working Capital | 681,500 | -5,627,100 | -3,364,200 | -5,385,000 | 163,700 |
| Other Operating Activity | -1,547,800 | 2,478,800 | 2,199,300 | 4,075,800 | 434,800 |
| Operating Cash Flow | $13,588,400 | $4,752,500 | $1,665,600 | $8,817,900 | $6,344,100 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 50,400 | N/A |
| PPE Investments | -5,294,300 | -3,206,600 | -1,509,500 | -5,057,800 | -3,561,800 |
| Net Acquisitions | -549,400 | N/A | N/A | -947,700 | -947,700 |
| Purchase Of Investment | -518,000 | -367,900 | -196,700 | -677,300 | -525,100 |
| Sale Of Investment | 832,000 | 275,900 | 71,600 | 373,600 | 318,000 |
| Other Investing Activity | -2,640,100 | -1,888,600 | -1,717,700 | -3,042,700 | -2,664,400 |
| Investing Cash Flow | $-8,169,800 | $-5,187,200 | $-3,352,300 | $-9,301,500 | $-7,381,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -4,337,600 | -245,900 | -1,848,700 | -1,851,800 | -4,894,100 |
| Debt Issued | 12,389,100 | 6,461,000 | 6,461,000 | 11,417,100 | 10,752,900 |
| Debt Repayment | N/A | -778,100 | N/A | -664,200 | N/A |
| Common Stock Issued | N/A | N/A | -686,300 | N/A | N/A |
| Common Stock Repurchased | -2,600,300 | -1,892,200 | -1,200,000 | -2,500,000 | -446,100 |
| Dividend Paid | -4,038,500 | -2,693,300 | -1,346,300 | -4,680,400 | -3,512,100 |
| Other Financing Activity | -746,900 | -716,700 | 0 | -490,600 | -445,100 |
| Financing Cash Flow | $665,800 | $134,800 | $1,379,700 | $1,230,100 | $1,455,500 |
| Exchange Rate Effect | 439,100 | 407,400 | 131,900 | -296,700 | 131,800 |
| Beginning Cash Position | 3,268,400 | 3,268,400 | 3,268,400 | 2,818,600 | 2,818,600 |
| End Cash Position | 9,791,900 | 3,375,900 | 3,093,300 | 3,268,400 | 3,369,000 |
| Net Cash Flow | $6,523,500 | $107,500 | $-175,100 | $449,800 | $550,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 13,588,400 | 4,752,500 | 1,665,600 | 8,817,900 | 6,344,100 |
| Capital Expenditure | -5,294,300 | -3,206,600 | -1,509,500 | -5,057,800 | -3,561,800 |
| Free Cash Flow | 8,294,100 | 1,545,900 | 156,100 | 3,760,100 | 2,782,300 |